Toxicology – Calcium Channel-Blocking Drugs (CCBs)

Core concept

Calcium channel blocker overdose is a potentially lethal cardiovascular poisoning characterized by vasodilation, myocardial depression, conduction disturbance, and impaired insulin secretion.

The classic severe syndrome is:

Hypotension + bradycardia/conduction block + hyperglycemia → shock

A useful mechanistic sequence is:

L-type Ca²⁺ channel blockade → ↓ cardiac contractility + ↓ SA/AV conduction + arterial vasodilation + ↓ pancreatic insulin release → cardiogenic/vasodilatory shock

Current resuscitation guidance emphasizes early high-dose insulin, vasopressors, and IV calcium rather than the older sequence of progressively trying atropine, dopamine, glucagon, and calcium.

Important CCB Classes

Non-dihydropyridines

Verapamil

Most prominent effects:

• Negative inotropy
• Bradycardia
• AV block
• Hypotension

Diltiazem

Similar to verapamil:

• Bradycardia
• AV nodal blockade
• Reduced contractility
• Hypotension

Dihydropyridines

Examples:

• Amlodipine
• Nifedipine
• Nicardipine
• Felodipine
• Isradipine
• Nimodipine
• Nisoldipine

At therapeutic concentrations these predominantly affect vascular smooth muscle, producing:

Peripheral vasodilation → hypotension → reflex tachycardia

However:

In massive overdose, receptor selectivity is lost.

Thus even amlodipine or nifedipine poisoning can eventually produce:

• Bradycardia
• AV block
• Severe myocardial depression
• Cardiogenic shock

Formulations

CCBs may be:

• Immediate release
• Extended release
• Sustained release

Extended-release products are particularly dangerous because they may cause:

Delayed onset + prolonged absorption + prolonged cardiovascular collapse

Occasionally, tablet concretions or pharmacobezoars contribute to prolonged toxicity.

Toxic Dose

There is no single reliable toxic dose applicable to all CCBs.

Severity depends on:

• Specific agent
• Dose
• Immediate- vs extended-release formulation
• Patient age/size
• Cardiac disease
• Hepatic function
• Coingestants

Historical teaching that approximately 1 g of verapamil, diltiazem, or nifedipine may cause severe adult toxicity is useful only as a rough warning, not a safe threshold.

Even relatively small exposures may be dangerous in young children.

Therefore:

Manage according to formulation, clinical findings, ECG, glucose, and hemodynamics—not dose alone.

Pathophysiology

CCBs inhibit L-type voltage-gated calcium channels.

Myocardium

Reduced intracellular calcium causes:

↓ Contractility → ↓ stroke volume → ↓ cardiac output

leading to:

• Hypotension
• Cardiogenic shock

SA and AV Nodes

Calcium current is particularly important for nodal depolarization.

Blockade therefore causes:

• Sinus bradycardia
• PR prolongation
• AV block
• Junctional rhythms
• Escape rhythms

This is most prominent with:

• Verapamil
• Diltiazem

Vascular Smooth Muscle

Reduced calcium entry produces:

Arteriolar vasodilation → ↓ systemic vascular resistance → hypotension

This is particularly prominent in:

• Amlodipine
• Nifedipine
• Other dihydropyridines

Pancreatic β Cells

Insulin secretion is calcium dependent.

Therefore:

CCB blockade → ↓ insulin secretion + insulin resistance → hyperglycemia

At the same time, shocked myocardium increasingly depends on glucose as an energy substrate.

Thus:

CCB poisoning → hypoinsulinemia + impaired myocardial glucose utilization → worsening myocardial dysfunction

This is a major rationale for high-dose insulin therapy.

Hyperglycemia – Important Diagnostic Clue

Hyperglycemia is characteristic of significant CCB toxicity.

It may correlate with severity because pancreatic β-cell calcium channels are inhibited.

A useful toxicologic contrast is:

CCB poisoning → hyperglycemia common

β-blocker poisoning → hypoglycemia may occur

This distinction is helpful but not absolute.

Clinical Features

Cardiovascular

The major findings are:

• Hypotension
• Bradycardia
• Sinus-node suppression
• PR prolongation
• AV block
• Junctional rhythms
• Intraventricular conduction abnormalities
• Reduced cardiac output
• Cardiogenic shock
• Ventricular dysrhythmias
• Cardiac arrest

Dihydropyridine poisoning

Early:

• Severe hypotension
• Reflex tachycardia

Massive overdose:

• Bradycardia
• Myocardial depression

Verapamil/diltiazem poisoning

More likely to produce:

• Severe bradycardia
• AV block
• Negative inotropy
• Cardiogenic shock

Shock Phenotypes

Severe poisoning can produce different forms of shock.

Vasodilatory shock

Especially common with dihydropyridines:

Low SVR + relatively preserved cardiac function

Cardiogenic shock

Especially common with verapamil/diltiazem:

Severely impaired contractility + low cardiac output

Mixed shock

Many severe patients develop:

Vasodilation + myocardial depression

Bedside echocardiography can therefore be extremely useful for guiding:

• Fluids
• Vasopressors
• Inotropes
• High-dose insulin
• ECMO decisions

Pulmonary

Severe poisoning may cause:

• Dyspnea
• Pulmonary edema
• Hypoxemic respiratory failure

Notably, noncardiogenic pulmonary edema can occur in severe CCB poisoning, particularly with profound precapillary vasodilation.

Excessive fluid administration can worsen pulmonary edema.

Neurologic

Possible effects include:

• Dizziness
• Weakness
• Syncope
• Confusion
• Somnolence

Severe shock may cause:

• Coma
• Seizures
• Hypoxic-ischemic injury

Primary seizures are uncommon; when present, consider:

• Severe cerebral hypoperfusion
• Hypoxia
• Coingestants

Gastrointestinal

Possible manifestations:

• Nausea
• Vomiting
• Ileus

Severe poisoning can impair gastrointestinal perfusion and motility.

Ileus is important because it may make whole-bowel irrigation unsafe or ineffective.

Metabolic Findings

Hyperglycemia

Characteristic and often clinically useful.

Metabolic acidosis

Usually reflects:

• Lactic acidosis
• Tissue hypoperfusion
• Shock

Electrolyte abnormalities

May develop secondary to:

• Shock
• Treatment
• High-dose insulin

During high-dose insulin, important concerns include:

• Hypoglycemia
• Hypokalemia

Diagnosis

Diagnosis is primarily:

Exposure history + cardiovascular toxidrome + ECG + hyperglycemia

There is no rapidly useful routine serum CCB concentration.

Essential Tests

Obtain:

• 12-lead ECG
• Continuous cardiac monitoring
• Blood pressure monitoring
• Serum glucose
• Electrolytes
• Potassium
• Magnesium
• Calcium
• Bicarbonate
• BUN
• Creatinine

For severe poisoning consider:

• Lactate
• Blood gas
• Serial glucose
• Serial electrolytes
• Bedside echocardiography

In intentional overdose also consider:

• Acetaminophen concentration
• Salicylate concentration
• Relevant coingestants

ECG Findings

Possible abnormalities include:

• Sinus bradycardia
• PR prolongation
• First-degree AV block
• Second- or third-degree AV block
• Junctional rhythm
• Escape rhythms
• Wide-complex rhythms in severe toxicity
• Ischemic changes secondary to shock

Continuous ECG monitoring is essential in significant poisoning.

Differential Diagnosis

Toxicologic

• β-blocker poisoning
• Digoxin toxicity
• Clonidine
• Class I antiarrhythmics
• Other antihypertensives

Medical

• Acute myocardial infarction
• Hyperkalemia
• Sinus-node disease
• AV conduction disease
• Severe hypothermia
• Cardiogenic shock from another cause

Treatment

Severe CCB poisoning frequently requires multiple therapies simultaneously.

The modern core treatment is:

IV calcium + high-dose insulin + vasopressors

with treatment tailored to whether shock is predominantly:

• Cardiogenic
• Vasodilatory
• Mixed

AHA recommends both high-dose insulin and vasopressors for life-threatening CCB-induced hypotension and considers IV calcium reasonable.

1. Initial Stabilization

Immediately provide:

• Airway assessment
• Supplemental oxygen when indicated
• IV/IO access
• Continuous ECG
• Continuous or frequent blood pressure monitoring
• Frequent glucose assessment

Severe cases should prompt early consultation with a poison center/medical toxicologist.

Because ECMO may take time to arrange, early consultation with an ECMO-capable center is appropriate when shock is rapidly progressing despite therapy.

2. IV Fluids

Give isotonic crystalloid when the patient is clinically fluid responsive.

A reasonable initial trial in hypotension may be approximately:

10–20 mL/kg crystalloid

followed by reassessment.

Do not repeatedly administer large volumes blindly.

CCB poisoning is often caused by:

• Vasoplegia
• Myocardial dysfunction

rather than true volume depletion.

Excess fluid can worsen:

• Pulmonary edema
• Ventricular dysfunction

Expert consensus recommends continuing fluids only when there is evidence of hemodynamic responsiveness.

3. IV Calcium

Calcium is an important first-line therapy.

It increases the extracellular calcium gradient and may temporarily improve:

• Contractility
• Blood pressure
• Conduction

Current expert recommendations include IV calcium among initial treatments for symptomatic CCB poisoning.

Calcium Chloride

A commonly used adult regimen:

10% calcium chloride 10–20 mL IV

equivalent to:

• 1–2 g calcium chloride

May be repeated approximately every:

10–20 minutes

according to response.

A continuous infusion may also be used in severe toxicity.

Important

Calcium chloride contains substantially more elemental calcium than calcium gluconate and is highly irritating if extravasated.

Prefer:

• Central venous access

when possible.

Calcium Gluconate

Common regimen:

10% calcium gluconate 30–60 mL IV

equivalent to:

• 3–6 g calcium gluconate

May be repeated approximately every:

10–20 minutes.

Calcium gluconate is safer through a peripheral IV.

Monitoring

During repeated/high-dose calcium therapy monitor:

• Ionized calcium
• ECG
• Clinical hemodynamic response

Do not treat the calcium concentration alone; the goal is improved perfusion and cardiovascular function.

4. High-Dose Insulin Euglycemia Therapy

Major modern therapy

High-dose insulin is one of the most important treatments for life-threatening CCB poisoning.

AHA gives high-dose insulin a Class 1 recommendation for hypotension caused by life-threatening CCB poisoning.

Mechanisms include:

• Positive inotropy
• Improved myocardial carbohydrate utilization
• Improved cellular glucose uptake
• Correction of the hypoinsulinemic state

Initial regimen

A commonly recommended starting regimen is:

Regular insulin 1 unit/kg IV bolus

followed by:

1 unit/kg/hour IV infusion

with dextrose as needed to maintain appropriate glucose concentrations.

Titration

If severe shock persists, insulin may be titrated upward to:

Up to approximately 10 units/kg/hour

in refractory life-threatening poisoning.

Treatment is titrated to:

• Blood pressure
• Cardiac output
• Peripheral perfusion
• Lactate trend
• Urine output
• Echocardiographic cardiac function

Dextrose

Patients frequently arrive hyperglycemic and may not initially need dextrose.

As glucose falls:

Give dextrose to maintain euglycemia.

High concentrations may be required during prolonged high-dose insulin therapy.

Potassium

Insulin shifts potassium intracellularly.

Therefore monitor potassium closely.

Mild hypokalemia may reflect redistribution rather than whole-body potassium depletion.

Avoid unnecessarily aggressive potassium replacement, particularly while the patient is improving.

Important adverse effects

• Hypoglycemia
• Hypokalemia
• Fluid overload from dextrose-containing infusions

Protocolized monitoring reduces these risks.

Important clinical point

High-dose insulin does not act instantly.

Hemodynamic improvement may be delayed.

Therefore continue other supportive treatments, especially:

• Calcium
• Vasopressors

while waiting for insulin’s inotropic effect.

5. Vasopressors

Vasopressors should be administered for life-threatening CCB-induced hypotension.

Norepinephrine

Particularly useful when the predominant physiology is:

Vasodilatory/vasoplegic shock

It is often preferred in severe dihydropyridine poisoning.

Epinephrine

Useful when hypotension is accompanied by:

• Bradycardia
• Reduced contractility
• Cardiogenic shock

because it provides:

• α-adrenergic vasoconstriction
• β₁ chronotropic/inotropic support

Dobutamine

May be considered when there is documented severe myocardial dysfunction with insufficient cardiac output.

Expert consensus recommends norepinephrine and/or epinephrine rather than older routine reliance on dopamine.

Dopamine

The historical source prioritizes dopamine.

Modern expert consensus specifically suggests not using dopamine as the preferred agent in CCB-induced shock, because response is inconsistent.

6. Atropine

Atropine may be attempted for:

• Symptomatic bradycardia
• AV conduction disturbance

However:

Severe CCB-induced bradycardia often responds poorly to atropine.

Failure should not delay:

• Calcium
• High-dose insulin
• Vasopressors

7. Glucagon

Older toxicology texts frequently recommended glucagon after failure of calcium and vasopressors.

Modern evidence is much less supportive.

AHA states:

The usefulness of glucagon in life-threatening CCB poisoning is uncertain.

Glucagon may:

• Increase cAMP independently of β receptors
• Occasionally improve heart rate or contractility

but responses are inconsistent.

Adverse effects include:

• Nausea
• Vomiting
• Hyperglycemia

Therefore:

Glucagon is not a core first-line antidotal therapy for CCB poisoning.

It may be considered as an adjunct in selected severe cases.

8. Cardiac Pacing

Temporary pacing may be attempted for:

• Unstable severe bradycardia
• High-grade AV block

especially if myocardial contractility is relatively preserved.

However:

Electrical capture does not guarantee mechanical cardiac output.

In profound CCB poisoning, the myocardium may be too depressed for pacing to substantially improve perfusion.

Expert consensus therefore reserves pacing mainly for severe bradycardia/high-grade block when major myocardial dysfunction is not dominant.

Do not let pacing delay:

• High-dose insulin
• Calcium
• Vasopressors

9. Methylene Blue

Methylene blue has been used as rescue therapy for severe:

Refractory vasoplegic shock

because it inhibits nitric oxide–mediated vasodilation.

However:

Evidence remains uncertain.

AHA states that its usefulness in refractory vasodilatory shock from CCB poisoning is uncertain.

Potential issues include:

• Serotonin toxicity with serotonergic medications
• Hemolysis in G6PD deficiency
• Interference with pulse oximetry

It should be considered only with specialist guidance in selected refractory cases.

10. Intravenous Lipid Emulsion

Highly lipophilic CCBs include:

• Verapamil
• Amlodipine

IV lipid emulsion has therefore been used as rescue therapy.

However:

Clinical evidence is inconsistent, and current AHA guidance considers its usefulness uncertain.

Potential adverse effects include:

• Pancreatitis
• Laboratory interference
• ARDS
• Fat overload

Thus:

ILE should generally be reserved for refractory life-threatening poisoning rather than routine early treatment.

11. VA-ECMO

For severe poisoning with:

Refractory cardiogenic or mixed shock despite calcium + high-dose insulin + vasopressors

consider:

Venoarterial extracorporeal membrane oxygenation (VA-ECMO)

AHA considers extracorporeal life support reasonable when severe CCB poisoning is refractory to pharmacologic therapy.

Because cannulation takes time:

Contact an ECMO-capable center early when a patient continues to deteriorate despite aggressive treatment.

VA-ECMO provides circulatory support while the drug is metabolized and redistributed.

Gastrointestinal Decontamination

Do Not Induce Vomiting

Emesis should not be induced.

Severe CCB poisoning can abruptly produce:

• Bradycardia
• Shock
• Altered consciousness
• Aspiration risk

Activated Charcoal

Activated charcoal may be considered after a significant recent ingestion when:

• The airway is intact/protected
• Aspiration risk is acceptable

Expert consensus supports considering charcoal following a potentially toxic exposure, especially when presentation is early.

It should never delay resuscitation.

Gastric Lavage

The historical routine recommendation for gastric lavage after a large ingestion does not reflect modern routine poisoning management.

It should only rarely be considered after an extremely recent, potentially lethal ingestion in a patient with:

• Protected airway
• Appropriate critical-care monitoring
• Toxicology consultation

Whole-Bowel Irrigation

Whole-bowel irrigation with polyethylene glycol may be considered for substantial sustained/extended-release CCB ingestion.

It is most appropriate when:

• The patient is hemodynamically stable enough to tolerate it
• Airway is protected as necessary
• Significant drug remains in the GI tract
• There is no ileus, bowel obstruction, or perforation

Extended-release formulations can cause prolonged or delayed toxicity, making GI decontamination more relevant than with many immediate-release exposures.

Important

Do not perform whole-bowel irrigation in a profoundly unstable patient simply to remove tablets.

Resuscitation takes priority.

Hemodialysis

Conventional hemodialysis is not effective for removal of most CCBs because they are:

• Highly protein bound
• Lipophilic
• Widely distributed
• Large-volume-of-distribution drugs

EXTRIP specifically recommends against extracorporeal toxin removal for amlodipine, diltiazem, and verapamil in severe poisoning.

Therefore:

Do not confuse VA-ECMO with hemodialysis.

• Hemodialysis: does not meaningfully remove most CCBs
• VA-ECMO: provides temporary circulatory support and may be lifesaving

Monitoring

Significant poisoning requires:

• Continuous ECG
• Continuous hemodynamic monitoring
• Serial neurologic assessment
• Serial glucose
• Serial potassium
• Magnesium
• Calcium
• Renal function
• Lactate/acid-base monitoring in severe shock

During high-dose insulin:

• Check glucose frequently
• Check potassium frequently
• Track dextrose and fluid requirements

Bedside echocardiography is highly useful for distinguishing:

• Vasodilatory shock
• Cardiogenic shock
• Mixed shock

and guiding treatment.

Admission

Hospital admission is appropriate for:

• Symptomatic exposure
• Hypotension
• Bradycardia
• AV block
• Significant hyperglycemia
• Metabolic acidosis
• Syncope
• Altered mental status
• Significant intentional overdose
• Extended-release ingestion

Patients with cardiovascular toxicity generally require:

ICU management

Observation

Potentially toxic ingestion

Current expert consensus favors approximately 24 hours of hospital observation for asymptomatic patients after a potentially toxic CCB ingestion, particularly when the formulation or dose creates concern.

The older rule:

“6 hours if immediate release, 24 hours if sustained release”

is too rigid for all circumstances.

Observation should account for:

• Specific agent
• Formulation
• Dose
• Coingestants
• ECG
• Glucose
• Comorbid disease

Extended-release ingestion deserves particularly prolonged monitoring because onset may be delayed.

Pregnancy

The historical FDA Pregnancy Category C system is obsolete.

Current drug labeling instead describes:

• Available pregnancy data
• Fetal risks
• Clinical considerations

In overdose, treatment priorities remain:

Maternal airway + circulation + correction of shock

because severe maternal hypotension threatens both maternal and fetal perfusion.

Necessary life-saving therapies should not be withheld solely because of pregnancy.

Prognosis

Mild exposures may resolve with observation.

Severe poisoning may have a prolonged course because:

• Absorption may continue from sustained-release products
• Hepatic metabolism can become saturated
• Cardiovascular collapse may persist for many hours

Poor prognostic features include:

• Refractory hypotension
• Severe myocardial dysfunction
• High-grade AV block
• Marked hyperglycemia
• Rising lactate/metabolic acidosis
• Pulmonary edema
• Need for escalating vasopressors

Even profound toxicity may be reversible with:

• High-dose insulin
• Aggressive hemodynamic support
• VA-ECMO when required

Important Pitfalls

1. Treating all CCBs identically

Remember:

Verapamil/diltiazem → bradycardia + AV block + cardiogenic shock

Amlodipine/nifedipine → vasodilatory shock, often tachycardic initially

But this distinction may disappear in massive overdose.

2. Missing hyperglycemia

Hyperglycemia is a characteristic clue to CCB poisoning.

It also provides mechanistic support for early high-dose insulin treatment.

3. Waiting too long to start high-dose insulin

High-dose insulin is not merely a last-resort treatment.

Current AHA guidance recommends it for life-threatening CCB-induced hypotension.

4. Relying on glucagon

Glucagon is far less established for CCB poisoning than older textbooks imply.

Its benefit is uncertain, and it should not delay:

• High-dose insulin
• Calcium
• Vasopressors

5. Using dopamine as the routine vasopressor

Modern expert consensus favors:

Norepinephrine and/or epinephrine

depending on the hemodynamic phenotype.

6. Giving excessive IV fluid

Severe CCB poisoning can cause:

• Cardiogenic shock
• Noncardiogenic pulmonary edema

Use fluids judiciously and reassess response.

7. Assuming pacing will correct the shock

Electrical pacing may raise heart rate without restoring:

• Contractility
• Stroke volume
• Blood pressure

Treat the myocardial poisoning itself.

8. Missing delayed extended-release toxicity

Sustained-release formulations may remain relatively silent initially and deteriorate later.

9. Dialyzing the patient to remove the CCB

Conventional hemodialysis is ineffective for:

• Amlodipine
• Diltiazem
• Verapamil

and most other CCBs.

10. Delaying ECMO referral

A crashing CCB patient may deteriorate faster than ECMO can be arranged.

Refractory shock should trigger early discussion with an ECMO-capable center.

High-Yield Toxicology Pearls

CCB overdose = hypotension + bradycardia ± hyperglycemia

Think:

Hyperglycemia + shock + bradycardia/AV block → calcium channel blocker toxicity

Important distinctions:

Verapamil/diltiazem → CARDIAC depression

Amlodipine/nifedipine → VASODILATION

but severe overdose causes loss of selectivity.

Key points:

• Mechanism: L-type calcium-channel blockade
• ↓ cardiac contractility
• ↓ SA/AV conduction
• Arterial vasodilation
• ↓ insulin secretion
• Characteristic metabolic clue: hyperglycemia
• Severe poisoning causes cardiogenic, vasodilatory, or mixed shock
• Continuous ECG and glucose monitoring are essential
• Main modern therapies:
• 
  
• IV calcium
• High-dose insulin
• Norepinephrine/epinephrine
• Typical high-dose insulin:
• 
  
• 1 U/kg IV bolus
• then 1 U/kg/h
• titrate in refractory cases up to approximately 10 U/kg/h
• Give dextrose as required to maintain euglycemia
• Monitor glucose and potassium closely
• Calcium chloride provides more elemental calcium but is more caustic
• Calcium gluconate is safer through peripheral access
• Atropine may be tried but is often ineffective
• Glucagon has uncertain benefit
• Pacing may fail when myocardial contractility is profoundly depressed
• Methylene blue and IV lipid emulsion are rescue therapies with uncertain evidence
• VA-ECMO can be lifesaving in refractory shock
• Activated charcoal may be considered after significant recent ingestion
• Whole-bowel irrigation may be useful for selected extended-release ingestions
• Conventional hemodialysis does not meaningfully remove most CCBs
• Sustained-release poisoning can be delayed and prolonged

Important CCB Classes Non-dihydropyridines Verapamil Most prominent effects:  Negative inotropy Bradycardia AV block Hypotension  Diltiazem Similar to verapamil:  Bradycardia AV nodal blockade Reduced contractility Hypotension  Dihydropyridines Examples:  Amlodipine Nifedipine Nicardipine Felodipine Isradipine Nimodipine Nisoldipine  At therapeutic concentrations these predominantly affect vascular smooth muscle, producing: Peripheral vasodilation → hypotension → reflex tachycardia However: In massive overdose, receptor selectivity is lost. Thus even amlodipine or nifedipine poisoning can eventually produce:  Bradycardia AV block Severe myocardial depression Cardiogenic shock

Formulations CCBs may be:  Immediate release Extended release Sustained release  Extended-release products are particularly dangerous because they may cause: Delayed onset + prolonged absorption + prolonged cardiovascular collapse Occasionally, tablet concretions or pharmacobezoars contribute to prolonged toxicity.

Toxic Dose There is no single reliable toxic dose applicable to all CCBs. Severity depends on:  Specific agent Dose Immediate- vs extended-release formulation Patient age/size Cardiac disease Hepatic function Coingestants  Historical teaching that approximately 1 g of verapamil, diltiazem, or nifedipine may cause severe adult toxicity is useful only as a rough warning, not a safe threshold. Even relatively small exposures may be dangerous in young children. Therefore: Manage according to formulation, clinical findings, ECG, glucose, and hemodynamics—not dose alone.

Pathophysiology CCBs inhibit L-type voltage-gated calcium channels. Myocardium Reduced intracellular calcium causes: ↓ Contractility → ↓ stroke volume → ↓ cardiac output leading to:  Hypotension Cardiogenic shock  SA and AV Nodes Calcium current is particularly important for nodal depolarization. Blockade therefore causes:  Sinus bradycardia PR prolongation AV block Junctional rhythms Escape rhythms  This is most prominent with:  Verapamil Diltiazem  Vascular Smooth Muscle Reduced calcium entry produces: Arteriolar vasodilation → ↓ systemic vascular resistance → hypotension This is particularly prominent in:  Amlodipine Nifedipine Other dihydropyridines  Pancreatic β Cells Insulin secretion is calcium dependent. Therefore: CCB blockade → ↓ insulin secretion + insulin resistance → hyperglycemia At the same time, shocked myocardium increasingly depends on glucose as an energy substrate. Thus: CCB poisoning → hypoinsulinemia + impaired myocardial glucose utilization → worsening myocardial dysfunction This is a major rationale for high-dose insulin therapy.

Hyperglycemia – Important Diagnostic Clue Hyperglycemia is characteristic of significant CCB toxicity. It may correlate with severity because pancreatic β-cell calcium channels are inhibited. A useful toxicologic contrast is: CCB poisoning → hyperglycemia common β-blocker poisoning → hypoglycemia may occur This distinction is helpful but not absolute.

Clinical Features Cardiovascular The major findings are:  Hypotension Bradycardia Sinus-node suppression PR prolongation AV block Junctional rhythms Intraventricular conduction abnormalities Reduced cardiac output Cardiogenic shock Ventricular dysrhythmias Cardiac arrest  Dihydropyridine poisoning Early:  Severe hypotension Reflex tachycardia  Massive overdose:  Bradycardia Myocardial depression  Verapamil/diltiazem poisoning More likely to produce:  Severe bradycardia AV block Negative inotropy Cardiogenic shock

Shock Phenotypes Severe poisoning can produce different forms of shock. Vasodilatory shock Especially common with dihydropyridines: Low SVR + relatively preserved cardiac function Cardiogenic shock Especially common with verapamil/diltiazem: Severely impaired contractility + low cardiac output Mixed shock Many severe patients develop: Vasodilation + myocardial depression Bedside echocardiography can therefore be extremely useful for guiding:  Fluids Vasopressors Inotropes High-dose insulin ECMO decisions

Pulmonary Severe poisoning may cause:  Dyspnea Pulmonary edema Hypoxemic respiratory failure  Notably, noncardiogenic pulmonary edema can occur in severe CCB poisoning, particularly with profound precapillary vasodilation. Excessive fluid administration can worsen pulmonary edema.

Neurologic Possible effects include:  Dizziness Weakness Syncope Confusion Somnolence  Severe shock may cause:  Coma Seizures Hypoxic-ischemic injury  Primary seizures are uncommon; when present, consider:  Severe cerebral hypoperfusion Hypoxia Coingestants

Gastrointestinal Possible manifestations:  Nausea Vomiting Ileus  Severe poisoning can impair gastrointestinal perfusion and motility. Ileus is important because it may make whole-bowel irrigation unsafe or ineffective.

Metabolic Findings Hyperglycemia Characteristic and often clinically useful. Metabolic acidosis Usually reflects:  Lactic acidosis Tissue hypoperfusion Shock  Electrolyte abnormalities May develop secondary to:  Shock Treatment High-dose insulin  During high-dose insulin, important concerns include:  Hypoglycemia Hypokalemia

Diagnosis Diagnosis is primarily: Exposure history + cardiovascular toxidrome + ECG + hyperglycemia There is no rapidly useful routine serum CCB concentration. Essential Tests Obtain:  12-lead ECG Continuous cardiac monitoring Blood pressure monitoring Serum glucose Electrolytes Potassium Magnesium Calcium Bicarbonate BUN Creatinine  For severe poisoning consider:  Lactate Blood gas Serial glucose Serial electrolytes Bedside echocardiography  In intentional overdose also consider:  Acetaminophen concentration Salicylate concentration Relevant coingestants

ECG Findings Possible abnormalities include:  Sinus bradycardia PR prolongation First-degree AV block Second- or third-degree AV block Junctional rhythm Escape rhythms Wide-complex rhythms in severe toxicity Ischemic changes secondary to shock  Continuous ECG monitoring is essential in significant poisoning.

Differential Diagnosis Toxicologic  β-blocker poisoning Digoxin toxicity Clonidine Class I antiarrhythmics Other antihypertensives  Medical  Acute myocardial infarction Hyperkalemia Sinus-node disease AV conduction disease Severe hypothermia Cardiogenic shock from another cause

Treatment Severe CCB poisoning frequently requires multiple therapies simultaneously. The modern core treatment is: IV calcium + high-dose insulin + vasopressors with treatment tailored to whether shock is predominantly:  Cardiogenic Vasodilatory Mixed  AHA recommends both high-dose insulin and vasopressors for life-threatening CCB-induced hypotension and considers IV calcium reasonable.

1. Initial Stabilization Immediately provide:  Airway assessment Supplemental oxygen when indicated IV/IO access Continuous ECG Continuous or frequent blood pressure monitoring Frequent glucose assessment  Severe cases should prompt early consultation with a poison center/medical toxicologist. Because ECMO may take time to arrange, early consultation with an ECMO-capable center is appropriate when shock is rapidly progressing despite therapy.

2. IV Fluids Give isotonic crystalloid when the patient is clinically fluid responsive. A reasonable initial trial in hypotension may be approximately: 10–20 mL/kg crystalloid followed by reassessment. Do not repeatedly administer large volumes blindly. CCB poisoning is often caused by:  Vasoplegia Myocardial dysfunction  rather than true volume depletion. Excess fluid can worsen:  Pulmonary edema Ventricular dysfunction  Expert consensus recommends continuing fluids only when there is evidence of hemodynamic responsiveness.

3. IV Calcium Calcium is an important first-line therapy. It increases the extracellular calcium gradient and may temporarily improve:  Contractility Blood pressure Conduction  Current expert recommendations include IV calcium among initial treatments for symptomatic CCB poisoning. Calcium Chloride A commonly used adult regimen: 10% calcium chloride 10–20 mL IV equivalent to:  1–2 g calcium chloride  May be repeated approximately every: 10–20 minutes according to response. A continuous infusion may also be used in severe toxicity. Important Calcium chloride contains substantially more elemental calcium than calcium gluconate and is highly irritating if extravasated. Prefer:  Central venous access  when possible. Calcium Gluconate Common regimen: 10% calcium gluconate 30–60 mL IV equivalent to:  3–6 g calcium gluconate  May be repeated approximately every: 10–20 minutes. Calcium gluconate is safer through a peripheral IV. Monitoring During repeated/high-dose calcium therapy monitor:  Ionized calcium ECG Clinical hemodynamic response  Do not treat the calcium concentration alone; the goal is improved perfusion and cardiovascular function.

4. High-Dose Insulin Euglycemia Therapy Major modern therapy High-dose insulin is one of the most important treatments for life-threatening CCB poisoning. AHA gives high-dose insulin a Class 1 recommendation for hypotension caused by life-threatening CCB poisoning. Mechanisms include:  Positive inotropy Improved myocardial carbohydrate utilization Improved cellular glucose uptake Correction of the hypoinsulinemic state  Initial regimen A commonly recommended starting regimen is: Regular insulin 1 unit/kg IV bolus followed by: 1 unit/kg/hour IV infusion with dextrose as needed to maintain appropriate glucose concentrations. Titration If severe shock persists, insulin may be titrated upward to: Up to approximately 10 units/kg/hour in refractory life-threatening poisoning. Treatment is titrated to:  Blood pressure Cardiac output Peripheral perfusion Lactate trend Urine output Echocardiographic cardiac function  Dextrose Patients frequently arrive hyperglycemic and may not initially need dextrose. As glucose falls: Give dextrose to maintain euglycemia. High concentrations may be required during prolonged high-dose insulin therapy. Potassium Insulin shifts potassium intracellularly. Therefore monitor potassium closely. Mild hypokalemia may reflect redistribution rather than whole-body potassium depletion. Avoid unnecessarily aggressive potassium replacement, particularly while the patient is improving. Important adverse effects  Hypoglycemia Hypokalemia Fluid overload from dextrose-containing infusions  Protocolized monitoring reduces these risks. Important clinical point High-dose insulin does not act instantly. Hemodynamic improvement may be delayed. Therefore continue other supportive treatments, especially:  Calcium Vasopressors  while waiting for insulin’s inotropic effect.

5. Vasopressors Vasopressors should be administered for life-threatening CCB-induced hypotension. Norepinephrine Particularly useful when the predominant physiology is: Vasodilatory/vasoplegic shock It is often preferred in severe dihydropyridine poisoning. Epinephrine Useful when hypotension is accompanied by:  Bradycardia Reduced contractility Cardiogenic shock  because it provides:  α-adrenergic vasoconstriction β₁ chronotropic/inotropic support  Dobutamine May be considered when there is documented severe myocardial dysfunction with insufficient cardiac output. Expert consensus recommends norepinephrine and/or epinephrine rather than older routine reliance on dopamine. Dopamine The historical source prioritizes dopamine. Modern expert consensus specifically suggests not using dopamine as the preferred agent in CCB-induced shock, because response is inconsistent.

6. Atropine Atropine may be attempted for:  Symptomatic bradycardia AV conduction disturbance  However: Severe CCB-induced bradycardia often responds poorly to atropine. Failure should not delay:  Calcium High-dose insulin Vasopressors

7. Glucagon Older toxicology texts frequently recommended glucagon after failure of calcium and vasopressors. Modern evidence is much less supportive. AHA states: The usefulness of glucagon in life-threatening CCB poisoning is uncertain. Glucagon may:  Increase cAMP independently of β receptors Occasionally improve heart rate or contractility  but responses are inconsistent. Adverse effects include:  Nausea Vomiting Hyperglycemia  Therefore: Glucagon is not a core first-line antidotal therapy for CCB poisoning. It may be considered as an adjunct in selected severe cases.

8. Cardiac Pacing Temporary pacing may be attempted for:  Unstable severe bradycardia High-grade AV block  especially if myocardial contractility is relatively preserved. However: Electrical capture does not guarantee mechanical cardiac output. In profound CCB poisoning, the myocardium may be too depressed for pacing to substantially improve perfusion. Expert consensus therefore reserves pacing mainly for severe bradycardia/high-grade block when major myocardial dysfunction is not dominant. Do not let pacing delay:  High-dose insulin Calcium Vasopressors

9. Methylene Blue Methylene blue has been used as rescue therapy for severe: Refractory vasoplegic shock because it inhibits nitric oxide–mediated vasodilation. However: Evidence remains uncertain. AHA states that its usefulness in refractory vasodilatory shock from CCB poisoning is uncertain. Potential issues include:  Serotonin toxicity with serotonergic medications Hemolysis in G6PD deficiency Interference with pulse oximetry  It should be considered only with specialist guidance in selected refractory cases.

10. Intravenous Lipid Emulsion Highly lipophilic CCBs include:  Verapamil Amlodipine  IV lipid emulsion has therefore been used as rescue therapy. However: Clinical evidence is inconsistent, and current AHA guidance considers its usefulness uncertain. Potential adverse effects include:  Pancreatitis Laboratory interference ARDS Fat overload  Thus: ILE should generally be reserved for refractory life-threatening poisoning rather than routine early treatment.

11. VA-ECMO For severe poisoning with: Refractory cardiogenic or mixed shock despite calcium + high-dose insulin + vasopressors consider: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) AHA considers extracorporeal life support reasonable when severe CCB poisoning is refractory to pharmacologic therapy. Because cannulation takes time: Contact an ECMO-capable center early when a patient continues to deteriorate despite aggressive treatment. VA-ECMO provides circulatory support while the drug is metabolized and redistributed.

Gastrointestinal Decontamination Do Not Induce Vomiting Emesis should not be induced. Severe CCB poisoning can abruptly produce:  Bradycardia Shock Altered consciousness Aspiration risk

Activated Charcoal Activated charcoal may be considered after a significant recent ingestion when:  The airway is intact/protected Aspiration risk is acceptable  Expert consensus supports considering charcoal following a potentially toxic exposure, especially when presentation is early. It should never delay resuscitation.

Gastric Lavage The historical routine recommendation for gastric lavage after a large ingestion does not reflect modern routine poisoning management. It should only rarely be considered after an extremely recent, potentially lethal ingestion in a patient with:  Protected airway Appropriate critical-care monitoring Toxicology consultation

Whole-Bowel Irrigation Whole-bowel irrigation with polyethylene glycol may be considered for substantial sustained/extended-release CCB ingestion. It is most appropriate when:  The patient is hemodynamically stable enough to tolerate it Airway is protected as necessary Significant drug remains in the GI tract There is no ileus, bowel obstruction, or perforation  Extended-release formulations can cause prolonged or delayed toxicity, making GI decontamination more relevant than with many immediate-release exposures. Important Do not perform whole-bowel irrigation in a profoundly unstable patient simply to remove tablets. Resuscitation takes priority.

Hemodialysis Conventional hemodialysis is not effective for removal of most CCBs because they are:  Highly protein bound Lipophilic Widely distributed Large-volume-of-distribution drugs  EXTRIP specifically recommends against extracorporeal toxin removal for amlodipine, diltiazem, and verapamil in severe poisoning. Therefore: Do not confuse VA-ECMO with hemodialysis.  Hemodialysis: does not meaningfully remove most CCBs VA-ECMO: provides temporary circulatory support and may be lifesaving

Monitoring Significant poisoning requires:  Continuous ECG Continuous hemodynamic monitoring Serial neurologic assessment Serial glucose Serial potassium Magnesium Calcium Renal function Lactate/acid-base monitoring in severe shock  During high-dose insulin:  Check glucose frequently Check potassium frequently Track dextrose and fluid requirements  Bedside echocardiography is highly useful for distinguishing:  Vasodilatory shock Cardiogenic shock Mixed shock  and guiding treatment.

Admission Hospital admission is appropriate for:  Symptomatic exposure Hypotension Bradycardia AV block Significant hyperglycemia Metabolic acidosis Syncope Altered mental status Significant intentional overdose Extended-release ingestion  Patients with cardiovascular toxicity generally require: ICU management

Observation Potentially toxic ingestion Current expert consensus favors approximately 24 hours of hospital observation for asymptomatic patients after a potentially toxic CCB ingestion, particularly when the formulation or dose creates concern. The older rule: “6 hours if immediate release, 24 hours if sustained release” is too rigid for all circumstances. Observation should account for:  Specific agent Formulation Dose Coingestants ECG Glucose Comorbid disease  Extended-release ingestion deserves particularly prolonged monitoring because onset may be delayed.

Pregnancy The historical FDA Pregnancy Category C system is obsolete. Current drug labeling instead describes:  Available pregnancy data Fetal risks Clinical considerations  In overdose, treatment priorities remain: Maternal airway + circulation + correction of shock because severe maternal hypotension threatens both maternal and fetal perfusion. Necessary life-saving therapies should not be withheld solely because of pregnancy.

Prognosis Mild exposures may resolve with observation. Severe poisoning may have a prolonged course because:  Absorption may continue from sustained-release products Hepatic metabolism can become saturated Cardiovascular collapse may persist for many hours  Poor prognostic features include:  Refractory hypotension Severe myocardial dysfunction High-grade AV block Marked hyperglycemia Rising lactate/metabolic acidosis Pulmonary edema Need for escalating vasopressors  Even profound toxicity may be reversible with:  High-dose insulin Aggressive hemodynamic support VA-ECMO when required

Important Pitfalls 1. Treating all CCBs identically Remember: Verapamil/diltiazem → bradycardia + AV block + cardiogenic shock Amlodipine/nifedipine → vasodilatory shock, often tachycardic initially But this distinction may disappear in massive overdose.

2. Missing hyperglycemia Hyperglycemia is a characteristic clue to CCB poisoning. It also provides mechanistic support for early high-dose insulin treatment.

3. Waiting too long to start high-dose insulin High-dose insulin is not merely a last-resort treatment. Current AHA guidance recommends it for life-threatening CCB-induced hypotension.

4. Relying on glucagon Glucagon is far less established for CCB poisoning than older textbooks imply. Its benefit is uncertain, and it should not delay:  High-dose insulin Calcium Vasopressors

5. Using dopamine as the routine vasopressor Modern expert consensus favors: Norepinephrine and/or epinephrine depending on the hemodynamic phenotype.

6. Giving excessive IV fluid Severe CCB poisoning can cause:  Cardiogenic shock Noncardiogenic pulmonary edema  Use fluids judiciously and reassess response.

7. Assuming pacing will correct the shock Electrical pacing may raise heart rate without restoring:  Contractility Stroke volume Blood pressure  Treat the myocardial poisoning itself.

8. Missing delayed extended-release toxicity Sustained-release formulations may remain relatively silent initially and deteriorate later.

9. Dialyzing the patient to remove the CCB Conventional hemodialysis is ineffective for:  Amlodipine Diltiazem Verapamil  and most other CCBs.

10. Delaying ECMO referral A crashing CCB patient may deteriorate faster than ECMO can be arranged. Refractory shock should trigger early discussion with an ECMO-capable center.

• High-Yield Toxicology Pearls CCB overdose = hypotension + bradycardia ± hyperglycemia Think: Hyperglycemia + shock + bradycardia/AV block → calcium channel blocker toxicity Important distinctions: Verapamil/diltiazem → CARDIAC depression Amlodipine/nifedipine → VASODILATION but severe overdose causes loss of selectivity. Key points:  Mechanism: L-type calcium-channel blockade ↓ cardiac contractility ↓ SA/AV conduction Arterial vasodilation ↓ insulin secretion Characteristic metabolic clue: hyperglycemia Severe poisoning causes cardiogenic, vasodilatory, or mixed shock Continuous ECG and glucose monitoring are essential Main modern therapies:
• 
  
• IV calcium High-dose insulin Norepinephrine/epinephrine  Typical high-dose insulin:
• 
  

1 U/kg IV bolus then 1 U/kg/h titrate in refractory cases up to approximately 10 U/kg/h  Give dextrose as required to maintain euglycemia Monitor glucose and potassium closely Calcium chloride provides more elemental calcium but is more caustic Calcium gluconate is safer through peripheral access Atropine may be tried but is often ineffective Glucagon has uncertain benefit Pacing may fail when myocardial contractility is profoundly depressed Methylene blue and IV lipid emulsion are rescue therapies with uncertain evidence VA-ECMO can be lifesaving in refractory shock Activated charcoal may be considered after significant recent ingestion Whole-bowel irrigation may be useful for selected extended-release ingestions Conventional hemodialysis does not meaningfully remove most CCBs Sustained-release poisoning can be delayed and prolonged